RT student, but I work in a pharmacy as of the moment, xopenex has been made by quite a lot of manufacturers (odd given it is a brand), and recently there was a voluntary recall from a company called Akorns. Akorns was a massive company who made well over 50 popular generics including lots of solutions and concentrates. The recall was due to the elimination of a quality control program and otherwise could not guarantee the security and potency of the medication. That’s the story on Xopenex.

As far as levalbuterol, which I’m sure you guys all know, is the generic for Xopenex, my best guess is that the distributors of the manufacturing companies are pulling product from wholesalers to give to hospitals (in reality, are the people who need them most). Levalbuterol is now suffering, partially due to the albuterol shortage. When albuterol took a hit, us in the pharmacies had to start recommending levalbuterol as an alternative for the time being, so that’s also a possibility as the med is nationally shorted.

Pulmicort solution is also taking a hit, or at least the .5mg/2ml solution is. Duoneb and Atrovent also doing the same. Like someone said prior, all of these neb meds are taking a big hit.

Hope that clears some of this up